Literature DB >> 22967062

Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-)) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.

M Sala1, D Braida, A Donzelli, R Martucci, M Busnelli, E Bulgheroni, T Rubino, D Parolaro, K Nishimori, B Chini.   

Abstract

We characterised the behavioural phenotype of mice heterozygous (Oxtr(+/-)) for the oxytocin receptor gene (Oxtr) and compared it with that of Oxtr null mice (Oxtr(-/-)), which display autistic-like behaviours, including impaired sociability and preference for social novelty, impaired cognitive flexibility, and increased aggression. Similar to Oxtr(-/-) mice, the Oxtr(+/-) showed impaired sociability and preference for social novelty but, unlike the null genotype, their cognitive flexibility and aggression were normal. By autoradiography, Oxtr(+/-) mice were found to have approximately 50% fewer oxytocin receptors (OXTRs) in all of the examined brain regions. Thus, because a partial reduction in Oxtr gene expression is sufficient to compromise social behaviour, the Oxtr acts as a haploinsufficient gene. Furthermore, the inactivation of the Oxtr gene affects specific behaviours in a dose-dependent manner: social behaviour is sensitive to even a partial reduction in Oxtr gene expression, whereas defects in aggression and cognitive flexibility require the complete inactivation of the Oxtr gene to emerge. We then investigated the rescue of the Oxtr(+/-) social deficits by oxytocin (OT) and Thr(4)Gly(7)OT (TGOT) administered i.c.v. at different doses. TGOT was more potent than OT in rescuing sociability and social novelty in both genotypes. Furthermore, the TGOT doses that reverted impaired sociability and preference for social novelty in Oxtr(+/-) were lower than those required in Oxtr(-/-), thus suggesting that the rescue effect is mediated by OXTR in Oxtr(+/-) and by other receptors (presumably vasopressin V1a receptors) in Oxtr(-/-). In line with this, a low dose of the selective oxytocin antagonist desGlyDTyrOVT blocks the rescue effect of TGOT only in the Oxtr(+/-) genotype, whereas the less selective antagonist SR49059 blocks rescue in both genotypes. In conclusion, the Oxtr(+/-) mouse is a unique animal model for investigating how partial loss of the Oxtr gene impair social interactions, and for designing pharmacological rescue strategies.
© 2012 British Society for Neuroendocrinology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22967062     DOI: 10.1111/j.1365-2826.2012.02385.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  32 in total

1.  Evidence for Association Between OXTR Gene and ASD Clinical Phenotypes.

Authors:  Lucas de Oliveira Pereira Ribeiro; Pedro Vargas-Pinilla; Djenifer B Kappel; Danae Longo; Josiane Ranzan; Michele Michelin Becker; Rudimar Dos Santos Riesgo; Lavinia Schuler-Faccini; Tatiana Roman; Jaqueline Bohrer Schuch
Journal:  J Mol Neurosci       Date:  2018-06-01       Impact factor: 3.444

Review 2.  Is birth a critical period in the pathogenesis of autism spectrum disorders?

Authors:  Yehezkel Ben-Ari
Journal:  Nat Rev Neurosci       Date:  2015-07-08       Impact factor: 34.870

Review 3.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

4.  Double Dissociation of the Roles of Metabotropic Glutamate Receptor 5 and Oxytocin Receptor in Discrete Social Behaviors.

Authors:  Ivana Mesic; Yomayra F Guzman; Anita L Guedea; Vladimir Jovasevic; Kevin A Corcoran; Katherine Leaderbrand; Katsuhiko Nishimori; Anis Contractor; Jelena Radulovic
Journal:  Neuropsychopharmacology       Date:  2015-03-31       Impact factor: 7.853

5.  Antiaggressive activity of central oxytocin in male rats.

Authors:  Federica Calcagnoli; Sietse F de Boer; Monika Althaus; Johan A den Boer; Jaap M Koolhaas
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

6.  Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice.

Authors:  Elisa Frullanti; Sonia Amabile; Maria Grazia Lolli; Anna Bartolini; Gabriella Livide; Elisa Landucci; Francesca Mari; Flora M Vaccarino; Francesca Ariani; Luca Massimino; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

7.  Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.

Authors:  Alberto Galbusera; Alessia De Felice; Stefano Girardi; Giacomo Bassetto; Marta Maschietto; Katsuhiko Nishimori; Bice Chini; Francesco Papaleo; Stefano Vassanelli; Alessandro Gozzi
Journal:  Neuropsychopharmacology       Date:  2016-12-20       Impact factor: 7.853

8.  WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.

Authors:  Callum Hicks; Linnet Ramos; Tristan A Reekie; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

9.  Social Communication is an Emerging Target for Pharmacotherapy in Autism Spectrum Disorder - A Review of the Literature on Potential Agents.

Authors:  Danielle A Baribeau; Evdokia Anagnostou
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-02

10.  Autism-relevant behaviors are minimally impacted by conditional deletion of Pten in oxytocinergic neurons.

Authors:  Amy E Clipperton-Allen; Youjun Chen; Damon T Page
Journal:  Autism Res       Date:  2016-05-25       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.